The risk of reinfection of the across mutation SARS-CoV-2 set the task of medicine to look for new ways to solve. One of these areas is the strengthening of innate T-lymphocyte immunity. Research on the use of an interferon inducer by stimulating innate T-lymphocyte immunity in order to innate prevent КОВИД-19 and its mutant forms and during the rehabilitation period after an illness, they give good scientific results and one of the future promising directions of prevention and treatment of КОВИД-19. Researchers have warned that the side effects of SARS-CoV-2 drugs include respiratory failure, decreased blood albumin levels, decreased red blood cells and platelets, anemia and coagulation disorders, jaundice, and liver damage. Adverse drug reactions include drug intoxication and adverse reactions, as well as immune reactions. For these reasons, the need to seek new methods of treatment and prevention and drugs has become one of the most pressing issues in modern medicine.